Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Huntington's disease (HD) is caused by polyglutamine expansion mutations in the huntingtin gene.
• Striatal neurons are preferentially vulnerable in HD, but the underlying mechanisms remain unclear.
• Mitochondrial dysfunction is implicated in HD pathogenesis, supported by postmortem data and toxin models.

Purpose of the Study:

• To review the nature and causes of mitochondrial dysfunction in HD striatal neurons.
• To integrate evidence from human patients, animal models, and cell cultures.
• To explore mechanisms by which mutant huntingtin (mHtt) contributes to striatal vulnerability.

Main Methods:

• Review of experimental evidence from patients, mice, primary cultures, and striatal cell lines.
• Analysis of mHtt's impact on mitochondrial function, including calcium handling, ATP production, and trafficking.
• Consideration of limitations in experimental approaches (isolated vs. in situ mitochondria, glia, glycolysis).

Main Results:

• Respiratory chain impairment appears to be a late, secondary event in HD pathogenesis.
• Upstream mitochondrial deficits in HD striatal neurons include impaired calcium handling, ATP production, and trafficking.
• mHtt may amplify striatal vulnerability through transcriptional abnormalities, reduced synaptic mitochondria trafficking, and direct structural interference.

Conclusions:

• Mitochondrial dysfunction in HD striatal neurons involves early, upstream defects rather than primary respiratory chain failure.
• mHtt-induced disruptions in mitochondrial calcium handling, ATP metabolism, and transport contribute to selective striatal vulnerability.
• Understanding these mechanisms offers insights into HD pathogenesis and potential therapeutic targets, drawing parallels with other neurodegenerative diseases.